References
- Lanier LL. 2005. Nk cell recognition. AnnuRevImmunol. 23:225–274.
- Manilay JO, Sykes M. 1998. Natural killer cells and their role in graft rejection. Curr Opin Immunol. 10(5):532–538.
- Herberman RB, Nunn ME, Holden HT, Lavrin DH. 1975. Natural cytotoxic reactivity of mouse lymphoid cells against syngeneic and allogeneic tumors. li. Characterization of effector cells. IntJCancer. 16(2):230–239.
- Kiessling R, Petranyi G, Klein G, Wigzel H. 1975. Genetic variation of in vitro cytolytic activity and in vivo rejection potential of non-immunized semi-syngeneic mice against a mouse lymphoma line. IntJCancer. 15(6):933–940.
- Ljunggren HG, Karre K. 1990. In search of the ‘missing self’: mhc molecules and nk cell recognition. ImmunolToday. 11(7):237–244.
- Velardi A, Ruggeri L, Mancusi A, Aversa F, Christiansen FT. 2009. Natural killer cell allorecognition of missing self in allogeneic hematopoietic transplantation: A tool for immunotherapy of leukemia. CurrOpinImmunol. 21(5):525–530.
- Yokoyama WM, Daniels BF, Seaman WE, Hunziker R, Margulies DH, Smith HR. 1995. A family of murine nk cell receptors specific for target cell mhc class i molecules. Semin Immunol. 7(2):89–101. doi:10.1006/smim.1995.0013.
- Snell GD, Jackson RB. 1958. Histocompatibility genes of the mouse. Ii. Production and analysis of isogenic resistant lines. J Natl Cancer Inst. 21(5):843–877.
- Cudkowicz G, Bennett M. 1971. Peculiar immunobiology of bone marrow allografts. Ii. Rejection of parental grafts by resistant f 1 hybrid mice. JExpMed. 134(6):1513–1528. doi:10.1084/jem.134.6.1513.
- Suzue K, Reinherz EL, Koyasu S. 2001. Critical role of nk but not nkt cells in acute rejection of parental bone marrow cells in f1 hybrid mice. EurJImmunol. 31(11):3147–3152.
- Kumar V, George T, Yu YY, Liu J, Bennett M. 1997. Role of murine nk cells and their receptors in hybrid resistance. CurrOpinImmunol. 9(1):52–56.
- Cook KD, Whitmire JK. 2013. The depletion of nk cells prevents t cell exhaustion to efficiently control disseminating virus infection. Journal Immunology (Baltimore, Md: 1950). 190(2):641–649. doi:10.4049/jimmunol.1202448.
- Soderquest K, Walzer T, Zafirova B, Klavinskis LS, Polic B, Vivier E, Lord GM, Martin-Fontecha A. 2011. Cutting edge: cd8+ t cell priming in the absence of nk cells leads to enhanced memory responses. Journal Immunology (Baltimore, Md: 1950). 186(6):3304–3308. doi:10.4049/jimmunol.1004122.
- Rydyznski C, Ka D, Ep K, Tr B, Se M, Mt M, Li C, Sutiwisesak R, Rm W, Sn W. 2015. Generation of cellular immune memory and b-cell immunity is impaired by natural killer cells. Nat Commun. 6:6375. doi:10.1038/ncomms7375.
- Cook KD, Kline HC, Whitmire JK. 2015. Nk cells inhibit humoral immunity by reducing the abundance of cd4+ t follicular helper cells during a chronic virus infection. J Leukoc Biol. 98(2):153–162. doi:10.1189/jlb.4HI1214-594R.
- George T, Yu YY, Liu J, Davenport C, Lemieux S, Stoneman E, Mathew PA, Kumar V, Bennett M. 1997. Allorecognition by murine natural killer cells: lysis of t-lymphoblasts and rejection of bone-marrow grafts. ImmunolRev. 155:29–40.
- Van Der Touw W, Bromberg JS. 2010. Natural killer cells and the immune response in solid organ transplantation. AmJTransplant. 10(6):1354–1358.
- Uehara S, Chase CM, Kitchens WH, Rose HS, Colvin RB, Russell PS, Madsen JC. 2005. Nk cells can trigger allograft vasculopathy: the role of hybrid resistance in solid organ allografts. JImmunol. 175(5):3424–3430. doi:10.4049/jimmunol.175.5.3424.
- Yu G, Xu X, Vu MD, Kilpatrick ED, Li XC. 2006. Nk cells promote transplant tolerance by killing donor antigen-presenting cells. JExpMed. 203(8):1851–1858. doi:10.1084/jem.20060603.
- Laffont S, Seillet C, Ortaldo J, Coudert JD, Guery JC. 2008. Natural killer cells recruited into lymph nodes inhibit alloreactive t-cell activation through perforin-mediated killing of donor allogeneic dendritic cells. Blood. 112(3):661–671. doi:10.1182/blood-2007-10-120089.
- Zecher D, Li Q, Oberbarnscheidt MH, Demetris AJ, Shlomchik WD, Rothstein DM, Lakkis FG. 2010. Nk cells delay allograft rejection in lymphopenic hosts by downregulating the homeostatic proliferation of cd8+ t cells. Journal Immunology (Baltimore, Md: 1950). 184(12):6649–6657. doi:10.4049/jimmunol.0903729.
- Lantow M, Eggenhofer E, Sabet-Baktach M, Renner P, Rovira J, Koehl GE, Schlitt HJ, Geissler EK, Kroemer A. 2015. Cd27low natural killer cells prolong allograft survival in mice by controlling alloreactive cd8+ t cells in a t-bet-dependent manner. Transplantation. 99(2):391–399. doi:10.1097/TP.0000000000000585.
- Auchincloss H Jr., Mayer T, Ghobrial R, Winn HJ. 1989. T-cell subsets, bm mutants, and the mechanisms of allogeneic skin graft rejection. ImmunolRes. 8(2):149–164.
- Rosenberg AS, Munitz TI, Maniero TG, Singer A. 1991. Cellular basis of skin allograft rejection across a class i major histocompatibility barrier in mice depleted of cd8+ t cells in vivo. JExpMed. 173(6):1463–1471. doi:10.1084/jem.173.6.1463.
- Le Moine A, Goldman M, Abramowicz D. 2002. Multiple pathways to allograft rejection. Transplantation. 73(9):1373–1381.
- Schulze DH, Pease LR, Geier SS, Reyes AA, Sarmiento LA, Wallace RB, Nathenson SG. 1983. Comparison of the cloned h-2kbm1 variant gene with the h-2kb gene shows a cluster of seven nucleotide differences. Proc Natl Acad Sci U S A. 80(7):2007–2011.
- Waldmann H. 2001. Therapeutic approaches for transplantation. CurrOpinImmunol. 13(5):606–610.
- Page EK, Dar WA, Knechtle SJ. 2012. Biologics in organ transplantation. TransplInt. 25(7):707–719. doi:10.1111/j.1432-2277.2012.01456.x.
- Ghobrial RR, Boublik M, Winn HJ, Auchincloss H Jr.. 1989. In vivo use of monoclonal antibodies against murine t cell antigens. Clin Immunol Immunopathol. 52(3):486–506.
- Betts MR, Brenchley JM, Price DA, De Rosa SC, Douek DC, Roederer M, Koup RA. 2003. Sensitive and viable identification of antigen-specific cd8+ t cells by a flow cytometric assay for degranulation. JImmunolMethods. 281(1–2):65–78.
- Ossevoort MA, De Bruijn ML, Van Veen KJ, Kast WM, Melief CJ. 1996. Peptide specificity of alloreactive cd4 positive t lymphocytes directed against a major histocompatibility complex class i disparity. Transplantation. 62(10):1485–1491.
- Oldstone MB. 2002. Biology and pathogenesis of lymphocytic choriomeningitis virus infection. Curr Top Microbiol Immunol. 263:83–117.
- Pallmer K, Oxenius A. 2016. Recognition and regulation of t cells by nk cells. Front Immunol. 7:251. doi:10.3389/fimmu.2016.00251.
- Andrews DM, Estcourt MJ, Andoniou CE, Wikstrom ME, Khong A, Voigt V, Fleming P, Tabarias H, Hill GR, Rg VDM, et al.. 2010. Innate immunity defines the capacity of antiviral t cells to limit persistent infection. J Exp Med. 207(6):1333–1343. doi:10.1084/jem.20091193.
- Waggoner SN, Cornberg M, Selin LK, Welsh RM. 2011. Natural killer cells act as rheostats modulating antiviral t cells. Nature. 481(7381):394–398. doi:10.1038/nature10624.
- Freitas AA, Rocha B. 2000. Population biology of lymphocytes: the flight for survival. AnnuRevImmunol. 18:83–111.
- Rocha B, Dautigny N, Pereira P. 1989. Peripheral t lymphocytes: expansion potential and homeostatic regulation of pool sizes and cd4/cd8 ratios in vivo. Eur J Immunol. 19(5):905–911. doi:10.1002/eji.1830190518.
- Gill RG. 2010. Nk cells: elusive participants in transplantation immunity and tolerance. Curr Opin Immunol. 22(5):649–654. doi:10.1016/j.coi.2010.09.005.
- Li XC, Demirci G, Ferrari-Lacraz S, Groves C, Coyle A, Malek TR, Strom TB. 2001. Il-15 and il-2: A matter of life and death for t cells in vivo. NatMed. 7(1):114–118.
- Sun JC, Lanier LL. 2011. Nk cell development, homeostasis and function: parallels with cd8(+) t cells. Nat Reviews Immunol. 11(10):645–657. doi:10.1038/nri3044.
- Fehniger TA, Cooper MA, Caligiuri MA. 2002. Interleukin-2 and interleukin-15: immunotherapy for cancer. Cytokine Growth Factor Rev. 13(2):169–183. doi:10.1016/S1359-6101(01)00021-1.
- Rabinovich BA, Li J, Shannon J, Hurren R, Chalupny J, Cosman D, Miller RG. 2003. Activated, but not resting, t cells can be recognized and killed by syngeneic nk cells. Journal Immunology (Baltimore, Md: 1950). 170(7):3572–3576.
- Lu L, Ikizawa K, Hu D, Werneck MB, Wucherpfennig KW, Cantor H. 2007. Regulation of activated cd4+ t cells by nk cells via the qa-1-nkg2a inhibitory pathway. Immunity. 26(5):593–604. doi:10.1016/j.immuni.2007.03.017.
- Sn W, Rt T, Pa M, Kumar V, Rm W. 2010. Absence of mouse 2b4 promotes nk cell-mediated killing of activated cd8+ t cells, leading to prolonged viral persistence and altered pathogenesis. J Clin Invest. 120(6):1925–1938. doi:10.1172/JCI41264.
- Crouse J, Bedenikovic G, Wiesel M, Ibberson M, Xenarios I, Von Laer D, Kalinke U, Vivier E, Jonjic S, Oxenius A. 2014. Type i interferons protect t cells against nk cell attack mediated by the activating receptor ncr1. Immunity. 40(6):961–973. doi:10.1016/j.immuni.2014.05.003.
- Goldrath AW, Bogatzki LY, Bevan MJ. 2000. Naive t cells transiently acquire a memory-like phenotype during homeostasis-driven proliferation. JExpMed. 192(4):557–564. doi:10.1084/jem.192.4.557.
- Boyman O, Purton JF, Surh CD, Sprent J. 2007. Cytokines and t-cell homeostasis. CurrOpinImmunol. 19(3):320–326.
- Yuan D, Bibi R, Dang T. 2004. The role of adjuvant on the regulatory effects of nk cells on b cell responses as revealed by a new model of nk cell deficiency. Int Immunol. 16(5):707–716. doi:10.1093/intimm/dxh071.
- Jukes JP, Wood KJ, Jones ND. 2007. Natural killer t cells: A bridge to tolerance or a pathway to rejection? Transplantation. 84(6):679–681. doi:10.1097/01.tp.0000280551.78156.ac.
- Stober D, Jomantaite I, Schirmbeck R, Reimann J. 2003. Nkt cells provide help for dendritic cell-dependent priming of mhc class i-restricted cd8+ t cells in vivo. Journal Immunology (Baltimore, Md: 1950). 170(5):2540–2548.
- Wu Z, Bensinger SJ, Zhang J, Chen C, Yuan X, Huang X, Markmann JF, Kassaee A, Rosengard BR, Hancock WW, et al. 2004. Homeostatic proliferation is a barrier to transplantation tolerance. NatMed. 10(1):87–92.
- Walzer T, Blery M, Chaix J, Fuseri N, Chasson L, Robbins SH, Jaeger S, Andre P, Gauthier L, Daniel L, et al. 2007. Identification, activation, and selective in vivo ablation of mouse nk cells via nkp46. Proc Natl Acad Sci U S A. 104(9):3384–3389. doi:10.1073/pnas.0609692104.
- Unkeless JC. 1979. Characterization of a monoclonal antibody directed against mouse macrophage and lymphocyte fc receptors. JExpMed. 150(3):580–596. doi:10.1084/jem.150.3.580.
- Rodriguez-Barbosa JI, Fernandez-Renedo C, Moral AMB, Buhler L, Del Rio ML. 2017. T follicular helper expansion and humoral-mediated rejection are independent of the hvem/btla pathway. Cell Mol Immunol. 14(6):497–510. doi:10.1038/cmi.2015.101.
- Del Rio ML, Cote-Sierra J, Rodriguez-Barbosa JI. 2011. Flt3l-mobilized dendritic cells bearing h2-kbm1 apoptotic cells do not induce cross-tolerance to cd8+ t cells across a class i mhc mismatched barrier. Transpl International: Official Journal Eur Soc Transplant. 24(5):501–513. doi:10.1111/j.1432-2277.2011.01220.x.
- Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, Schuler G. 1999. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. JImmunolMethods. 223(1):77–92.
- Del Rio ML, Jones ND, Buhler L, Norris P, Shintani Y, Ware CF, Rodriguez-Barbosa JI. 2012. Selective blockade of herpesvirus entry mediator-b and t lymphocyte attenuator pathway ameliorates acute graft-versus-host reaction. JImmunol. 188(10):4885–4896. doi:10.4049/jimmunol.1103698.
- Lyons AB. 2000. Analysing cell division in vivo and in vitro using flow cytometric measurement of cfse dye dilution. JImmunolMethods. 243(1–2):147–154.
- Del Rio ML, Kurtz J, Perez-Martinez C, Ghosh A, Perez-Simon JA, Rodriguez-Barbosa JI. 2011. B- and t-lymphocyte attenuator targeting protects against the acute phase of graft versus host reaction by inhibiting donor anti-host cytotoxicity. Transplantation. 92(10):1085–1093. doi:10.1097/TP.0b013e3182339d4a.